Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease

Recruiting now · Not applicable

Conditions studied: Vogt Koyanagi Harada Disease

In brief

This prospective study will include patients with Vogt-Koyanagi-Harada disease from disease onset, treated with early systemic high-dose corticosteroid and immunosuppressive therapy. Clinical and subclinical signs of disease activity added with electroretinogram exams, through predefined intervals, will be evaluated through a minimum 12-month follow-up.

Key facts

Study ID

NCT03399175

Run by

University of Sao Paulo

People needed

40

Starts

2015-03-23

Expected to finish

2028-12-01

Last updated by the study team

2026-05-07

Who can join

Age: 10 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• acute Vogt-Koyanagi-Harada disease

You may not qualify if…

• non collaborative patient
• minimum one-year follow-up

Where it is running

• Hospital das Clinicas HCFMUSP, Faculdade de Medicina Universidade de Sao Paulo — São Paulo, São Paulo, Brazil (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.